Skip to search.
 TSX Down 0.88% TSX Ventures Down 3.31%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
0.36 Up 0.00(0.73%) 3:44PM EDT - Nasdaq Real Time Price
Prev Close:0.35
Open:0.35
Bid:0.35 x 2100
Ask:0.36 x 600
1y Target Est:1.92
Beta:0.473065
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:0.35 - 0.38
52wk Range:0.25 - 1.75
Volume:859,843
Avg Vol (3m):1,302,180
Market Cap:100.82M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CTICUp 0.73%100.82M
BMYDown 2.35%97.67B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.19
Quarterly EPS Est (Sep-16) :-0.07
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback